These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15383171

  • 21. Telithromycin new product overview.
    File TM.
    J Allergy Clin Immunol; 2005 Feb; 115(2):S1-13. PubMed ID: 15696068
    [Abstract] [Full Text] [Related]

  • 22. Cethromycin: a promising new ketolide antibiotic for respiratory infections.
    Rafie S, MacDougall C, James CL.
    Pharmacotherapy; 2010 Mar; 30(3):290-303. PubMed ID: 20180612
    [Abstract] [Full Text] [Related]

  • 23. Telithromycin--a ketolide antibiotic for the treatment of outpatients with community-acquired respiratory tract infections.
    Counts M.
    Clin Nurse Spec; 2005 Mar; 19(3):121-3. PubMed ID: 15897765
    [No Abstract] [Full Text] [Related]

  • 24. Telithromycin.
    Spiers KM, Zervos MJ.
    Expert Rev Anti Infect Ther; 2004 Oct; 2(5):685-93. PubMed ID: 15482232
    [Abstract] [Full Text] [Related]

  • 25. Clinical and economic outcomes in the treatment of lower respiratory tract infections.
    Brixner DI.
    Am J Manag Care; 2004 Oct; 10(12 Suppl):S400-7. PubMed ID: 15603249
    [No Abstract] [Full Text] [Related]

  • 26. Synthesis and antibacterial activity of novel modified 5-O-mycaminose 14-membered ketolides.
    Xu Y, Chen X, Zhu D, Liu Y, Zhao Z, Jin L, Liu C, Lei P.
    Eur J Med Chem; 2013 Nov; 69():174-81. PubMed ID: 24021890
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chains.
    Chen XZ, Xu P, Liu L, Zheng D, Lei PS.
    Eur J Med Chem; 2011 Jan; 46(1):208-17. PubMed ID: 21130543
    [Abstract] [Full Text] [Related]

  • 28. Cethromycin: a new ketolide antibiotic.
    Mansour H, Chahine EB, Karaoui LR, El-Lababidi RM.
    Ann Pharmacother; 2013 Mar; 47(3):368-79. PubMed ID: 23463743
    [Abstract] [Full Text] [Related]

  • 29. Safeguarding future antimicrobial options: strategies to minimize resistance.
    Leclercq R.
    Clin Microbiol Infect; 2001 Mar; 7 Suppl 3():18-23. PubMed ID: 11523557
    [Abstract] [Full Text] [Related]

  • 30. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B.
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [Abstract] [Full Text] [Related]

  • 31. Antibiotic resistance: where do ketolides fit?
    White RL.
    Pharmacotherapy; 2002 Jan; 22(1 Pt 2):18S-29S; discussion 30S-32S. PubMed ID: 11791625
    [Abstract] [Full Text] [Related]

  • 32. 9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens.
    Nomura T, Yasukata T, Narukawa Y, Uotani K.
    Bioorg Med Chem; 2005 Nov 01; 13(21):6054-63. PubMed ID: 15994088
    [Abstract] [Full Text] [Related]

  • 33. Telithromycin in lower respiratory tract infections.
    Blasi F, Cazzola M, Tarsia P, Aliberti S, Baldessari C, Valenti V.
    Future Microbiol; 2006 Jun 01; 1(1):7-16. PubMed ID: 17661681
    [Abstract] [Full Text] [Related]

  • 34. Managing acute lower respiratory tract infections in an era of antibacterial resistance.
    Volturo GA, Low DE, Aghababian R.
    Am J Emerg Med; 2006 May 01; 24(3):329-42. PubMed ID: 16635707
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.
    Edlund C, Alván G, Barkholt L, Vacheron F, Nord CE.
    J Antimicrob Chemother; 2000 Nov 01; 46(5):741-9. PubMed ID: 11062193
    [Abstract] [Full Text] [Related]

  • 36. C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, Inc.
    Poce G, Cesare Porretta G, Biava M.
    Expert Opin Ther Pat; 2009 Jun 01; 19(6):901-6. PubMed ID: 19473109
    [Abstract] [Full Text] [Related]

  • 37. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
    Pavlović D, Fajdetić A, Mutak S.
    Bioorg Med Chem; 2010 Dec 15; 18(24):8566-82. PubMed ID: 21055953
    [Abstract] [Full Text] [Related]

  • 38. [Resistance of respiratory tract infection agents is still increasing. Is its time for new antibiotic strategies?].
    MMW Fortschr Med; 2003 Feb 27; 145(9):55. PubMed ID: 12666535
    [No Abstract] [Full Text] [Related]

  • 39. [Advance in synthesis of ketolides, a new class of erythromycin derivatives].
    Lei PS, Xu P, Liu L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug 27; 26(4):467-73. PubMed ID: 15379279
    [Abstract] [Full Text] [Related]

  • 40. Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
    Fernandes P, Pereira D, Watkins PB, Bertrand D.
    J Med Chem; 2020 Jun 25; 63(12):6462-6473. PubMed ID: 31644280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.